Evidence map›Paper›PMID 36718388›Full record

ArticleConcurrency and computation : practice & experience2023

Poor and rich dolphin optimization algorithm with modified deep fuzzy clustering for COVID-19 patient analysis.

Sudhagar Dhandapani, Arokia Renjit Jerald Rodriguez

Open access · greenAbstract read
In one paragraph

Article in Concurrency and computation : practice & experience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sudhagar DhandapaniJerusalem College of Engineering Chennai India.ORCID https://orcid.org/0000-0002-1198-7811
Arokia Renjit Jerald RodriguezDepartment of Computer Science and Engineering Jeppiaar Engineering College Chennai India.ORCID https://orcid.org/0000-0003-3895-2907
Azrieli College of Engineering Jerusalem · ILJeppiaar Engineering College

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Coronavirus disease 2019 (COVID-19) is considered as a pandemic by the World Health Organization (WHO), which has spread worldwide. Over millions of peoples are infected across the globe and several people are died. However, the most worrying group of patients suffered from lung severity with respiratory failure. Hence, cluster analysis is utilized for examining the heterogeneity of diseases for determining various clinical phenotypes having the same traits. This article devises an optimization-driven technique for COVID-19 patient analysis using the spark framework. Here, the input data is partitioned and fed to different slave nodes. In slave node, the selection of imperative features is done using the proposed poor and rich dolphin optimization algorithm (PRDOA). The proposed PRDOA is obtained by combining poor and rich (PRO) and dolphin echolation (DE) algorithm. The fitness is newly devised considering Minkowski distance measure. The clustering is performed on the master node using the proposed Tanimoto-based deep fuzzy clustering (TDFC) for effective COVID-19 patient analysis. Thus, the proposed TDFC is obtained by incorporating Tanimoto concept and deep fuzzy clustering. The proposed PRDOA with TDFC offered enhanced performance with the highest clustering accuracy of 89.8%, dice coefficient of 90%, Jaccard coefficient of 85.7%, and rand coefficient of 85.7%.

Indexed as

Coronavirus disease 2019 patient analysisdeep fuzzy clusteringMinkowski distancespark architectureTanimoto distance

Identifiers

PMID36718388
PMCPMC9877607
OpenAlexW4308934305

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.